George Clinical welcomes the development of the INVICTUS program which was launched at the World Heart Federation’s World Congress of Cardiology and Cardiovascular Health recently. The study, supported by Bayer AG and endorsed by the World Heart Federation, will be conducted by George Clinical in China and reinforces the importance of scientific leadership when undertaking […]
Read More
Philip Gregory of George Clinical – China, highlight South Korea’s capabilities in a three part series originally published on http://innovations.bbkworldwide.com/part-ii-insights-on-the-clinical-trial-landscape-of-south-korea. He provides insight on its recent clinical research developments that are driving innovation across the Asia-Pacific region. South Korea In comparison to Japan, South Korea has had a longer history of conducting global clinical trials. In fact, more than […]
Read More
Philip Gregory of George Clinical focuses on China, in a three part series originally published on http://innovations.bbkworldwide.com/part-iii-chinas-future-in-global-clinical-research that discusses developments in the clinical trial landscape of East Asia and Japan. Active international collaboration has facilitated the rise of the Asia-Pacific region in global clinical research. With the world’s largest population, China’s recent changes to their clinical trial processes and […]
Read MoreSponsors are increasingly seeking emerging areas to conduct clinical trials for new patient pools and better recruitment. However, successful implementation of a global clinical trial in areas such as South East Asia requires operational strategies that circumvents the inherent diversity of these regions. In these regions, language, culture, infrastructure and resources are very different from […]
Read More
Throughout clinical trials, the data manager (DM) is heavily involved in constructing databases, managing reports, programming quality checks and managing the collection of data in the clinical trial. The DM is responsible for managing and training users the concepts of computerised clinical data base systems as well as fulfilling other duties such as design basic […]
Read More
New research from the International Childhood Cancer Cohort Consortium (I4C) confirms that childhood cancer is linked to birthweight. Childhood cancer appears to be slowly rising, at a rate of approximately 1% per year in developed countries. The I4C is an alliance of several large-scale studies of children that pools data on factors in relation to […]
Read More
George Clinical (GC) conducted a brief survey on sponsors who are currently not a customer of GC. 30 companies were surveyed by GC’s Business Development Managers across six countries which included the United States, China, Australia, Korea, United Kingdom and Israel. The primary objective of the survey was to determine the services and countries that were important […]
Read MoreThe Therapeutic Goods Administration (TGA) has released a new online form for the clinical trial notification (CTN) scheme. When a clinical trial is investigating the use of a product within Australia, which is not on the Australian Register of Therapeutic Goods (ARTG), or on the ARTG yet being used outside its marketing approval conditions, these […]
Read More
George Clinical has expanded its coverage in Asia to include Japan.
Read More
Recently, the FDA said it will review possible heart risks associated with saxagliptin, a widely used diabetes drug.
Read More
